Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2006 Jun;98(6):956–958.

Wegener's granulomatosis with a possible thyroidal involvement.

Hakan Ozdogu 1, Can Boga 1, Filiz Bolat 1, Melek Eda Ertorer 1
PMCID: PMC2569360  PMID: 16775921

Abstract

Wegener's granulomatosis (WG) is an autoimmune disorder characterized by the involvement of many organ systems. In patients with refractory disease, the efficacy of cyclophosphamide, corticosteroids and infliximab has been reported recently. Even in cases with serological response, disease progression has still been observed. Herein, we report a case of WG, most likely accompanied with subacute granulomatous thyroiditis while the patient was on cyclophosphamide, corticosteroid and infliximab therapy. As far as we know, this is the first time that such a copresentation has been observed, suggesting that mechanisms other than T-cell-mediated cytotoxicity may be important in the pathogenesis of granulomatous thyroiditis.

Full text

PDF
956

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Booth A. D., Jayne D. R. W., Kharbanda R. K., McEniery C. M., Mackenzie I. S., Brown J., Wilkinson I. B. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation. 2004 Mar 22;109(14):1718–1723. doi: 10.1161/01.CIR.0000124720.18538.DD. [DOI] [PubMed] [Google Scholar]
  2. Kerr G. S., Fleisher T. A., Hallahan C. W., Leavitt R. Y., Fauci A. S., Hoffman G. S. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum. 1993 Mar;36(3):365–371. doi: 10.1002/art.1780360312. [DOI] [PubMed] [Google Scholar]
  3. Lamprecht P., Voswinkel J., Lilienthal T., Nolle B., Heller M., Gross W. L., Gause A. Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis. Rheumatology (Oxford) 2002 Nov;41(11):1303–1307. doi: 10.1093/rheumatology/41.11.1303. [DOI] [PubMed] [Google Scholar]
  4. Martino E., Buratti L., Bartalena L., Mariotti S., Cupini C., Aghini-Lombardi F., Pinchera A. High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest. 1987 Jun;10(3):321–323. doi: 10.1007/BF03348138. [DOI] [PubMed] [Google Scholar]
  5. Ohsako N., Tamai H., Sudo T., Mukuta T., Tanaka H., Kuma K., Kimura A., Sasazuki T. Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab. 1995 Dec;80(12):3653–3656. doi: 10.1210/jcem.80.12.8530615. [DOI] [PubMed] [Google Scholar]
  6. Pettersson E., Heigl Z. Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study. Clin Nephrol. 1992 May;37(5):219–228. [PubMed] [Google Scholar]
  7. Reinhold-Keller E., Beuge N., Latza U., de Groot K., Rudert H., Nölle B., Heller M., Gross W. L. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000 May;43(5):1021–1032. doi: 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES